Clinical Trials Directory

Trials / Unknown

UnknownNCT04517955

TAVI in Intermediate Risk Septuagenarians With Risk Factors Not Captured by the Traditional Surgical Risk Scores

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University of Athens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Single arm, observational trial of Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic Evolut R and Evolut Pro The primary objective of this trial is to evaluate device success of TAVI with the Evolut R and Evolut Pro systems in septuagenarians with risk factors for adverse surgical outcomes not captured by the traditional risk scores and therefore of intermediate surgical risk.

Detailed description

The purpose of this study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in septuagenarians with severe, symptomatic Aortic Stenosis (AS) and risk factors for adverse surgical outcomes not captured by the traditional risk scores and therefore of intermediate surgical risk. The primary objective of this trial is to evaluate device success of TAVI with the Evolut R and Evolut Pro systems in septuagenarians with risk factors for adverse surgical outcomes not captured by the traditional risk scores and therefore of intermediate surgical risk. The secondary objective is to assess early safety (at 30 days) and clinical efficacy (after 30 days) of the TAVI procedure. Exploratory objective: comparative health economics in septuagenarians with symptomatic severe aortic stenosis and intermediate surgical risk treated with Transcatheter Aortic Valve Implantation (TAVI) vs Surgical Aortic Valve Replacement (SAVR) (matched historic cohort)

Conditions

Interventions

TypeNameDescription
DEVICETranscatheter Aortic Valve Implantation (TAVI)Transcatheter Aortic Valve Implantation with Evolut R or Evolut Pro

Timeline

Start date
2020-07-01
Primary completion
2022-09-01
Completion
2025-03-30
First posted
2020-08-19
Last updated
2020-08-19

Locations

5 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT04517955. Inclusion in this directory is not an endorsement.